Ligand validation:2QCL

OMP: OROTIDINE-5'-MONOPHOSPHATE

OMP is a Ligand Of Interest in 2QCL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QCL_OMP_B_2	94%	12%	0.076	0.976	2.34	1.71	1	5	1	0	100%	1
2QCL_OMP_A_1	89%	13%	0.084	0.963	2.44	1.56	2	5	1	0	100%	1
7AM9_OMP_A_501	100%	20%	0.039	0.997	1.04	2.32	2	3	0	0	100%	0.72
7OQI_OMP_A_504	100%	35%	0.045	0.996	1.06	1.47	2	2	0	0	100%	0.51
6ZX0_OMP_A_501	100%	32%	0.041	0.991	1.1	1.59	2	2	0	0	100%	0.75
6YVO_OMP_A_501	100%	31%	0.041	0.988	1.12	1.62	2	3	0	0	100%	0.72
7OQF_OMP_A_504	100%	33%	0.047	0.994	1.08	1.58	1	2	0	0	100%	0.69
7OQM_OMP_A_504	100%	33%	0.049	0.995	0.92	1.71	1	3	0	0	100%	14.000000000000002

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.